A PHASE I, RANDOMIZED, DOUBLE BLIND PLACEBO * CONTROLLED, SINGLE AND MULTIPLE DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF OCID 2987 IN HEALTHY MALE SUBJECTS - OCID 2987 SAD/MAD study

Start Date29 Mar 2011

Sponsor / Collaborator

Orchid Research Laboratories Ltd.

100 Clinical Results associated with Orchid Research Laboratories Ltd.

0 Patents (Medical) associated with Orchid Research Laboratories Ltd.

Literatures (Medical) associated with Orchid Research Laboratories Ltd.

01 Jul 2010·Infection and ImmunityQ2 · MEDICINE

NlpI Contributes to Escherichia coli K1 Strain RS218 Interaction with Human Brain Microvascular Endothelial Cells

Q2 · MEDICINE

Article

Author: Teng, Ching-Hao ; Paul-Satyaseela, Maneesh ; Pearce, Donna ; Xie, Yi ; Tseng, Yu-Ting ; Maruvada, Ravi ; Kim, Kwang Sik

ABSTRACTEscherichia coli K1 is the most common Gram-negative bacillary organism causing neonatal meningitis. E. coli K1 binding to and invasion of human brain microvascular endothelial cells (HBMECs) is a prerequisite for its traversal of the blood-brain barrier (BBB) and penetration into the brain. In the present study, we identified NlpI as a novel bacterial determinant contributing to E. coli K1 interaction with HBMECs. The deletion of nlpI did not affect the expression of the known bacterial determinants involved in E. coli K1-HBMEC interaction, such as type 1 fimbriae, flagella, and OmpA, and the contribution of NlpI to HBMECs binding and invasion was independent of those bacterial determinants. Previous reports have shown that the nlpI mutant of E. coli K-12 exhibits growth defect at 42°C at low osmolarity, and its thermosensitive phenotype can be suppressed by a mutation on the spr gene. The nlpI mutant of strain RS218 exhibited similar thermosensitive phenotype, but additional spr mutation did not restore the ability of the nlpI mutant to interact with HBMECs. These findings suggest the decreased ability of the nlpI mutant to interact with HBMECs is not associated with the thermosensitive phenotype. NlpI was determined as an outer membrane-anchored protein in E. coli , and the nlpI mutant was defective in cytosolic phospholipase A 2 α (cPLA 2 α) phosphorylation compared to the parent strain. These findings illustrate the first demonstration of NlpI's contribution to E. coli K1 binding to and invasion of HBMECs, and its contribution is likely to involve cPLA 2 α.

01 Jan 2008·The Journal of Toxicological SciencesQ4 · MEDICINE

Evaluation of statistical tools used in short-term repeated dose administration toxicity studies with rodents

Q4 · MEDICINE

Article

Author: Kobayashi, Katsumi ; Sakuratani, Yuki ; Pillai, K. Sadasivan ; Abe, Takemaru ; Hayashi, Makoto ; Kamata, Eiichi

In order to know the different statistical tools used to analyze the data obtained from twenty-eight-day repeated dose oral toxicity studies with rodents and the impact of these statistical tools on interpretation of data obtained from the studies, study reports of 122 numbers of twenty-eight-day repeated dose oral toxicity studies conducted in rats were examined. It was found that both complex and easy routes of decision trees were followed for the analysis of the quantitative data. These tools include Scheffe's test, non-parametric type Dunnett's and Scheffe's tests with very low power. Few studies used the non-parametric Dunnett type test and Mann-Whitney's U test. Though Chi-square and Fisher's tests are widely used for analysis of qualitative data, their sensitivity to detect a treatment-related effect is questionable. Mann-Whitney's U test has better sensitivity to analyze qualitative data than the chi-square and Fisher's tests. We propose Dunnett's test for analysis of quantitative data obtained from twenty-eight-day repeated dose oral toxicity tests and for qualitative data, Mann-Whitney's U test. For both tests, one-sided test with p=0.05 may be applied.

Analytical Chemistry: An Indian Journal

Determination of residual formic acid in ceftazidime drug substances using ion chromatography by facile non-suppressed conductivity detection

Author: Murugan, Ramalingam ; Narayanan, S. Sriman

A simple and sensitive ion chromatog. method, for the determination of residual formic acid in sterile ceftazidime drug substance was developed and validated.The formate ion was separated from the drug substance by an acid selective ion exchange column.The mobile phase was 10% acetone and 90% of aqueous sulfuric acid (5 × 10^-4 M).This method was linear over the concentration in the range of 0.25 μg/mL to 25.33 μg/mL with r²> 0.98 and the signal-to-noise ratio 0.065.This method was validated in terms of Selectivity, Linearity, Precision, Accuracy, Robustness, Limit of detection (LOD), Limit of quantitation (LOQ).This method was successfully applied for formulated and drug substance of ceftazidime.

100 Deals associated with Orchid Research Laboratories Ltd.

100 Translational Medicine associated with Orchid Research Laboratories Ltd.

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 24 Jan 2025

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Orchid Research Laboratories Ltd.

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 24 Jan 2025

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing